1.The Low FODMAP Diet and Its Application in East and Southeast Asia.
Marina IACOVOU ; Victoria TAN ; Jane G MUIR ; Peter R GIBSON
Journal of Neurogastroenterology and Motility 2015;21(4):459-470
There is growing interest in using food choice/dietary change to influence clinical outcomes in patients with irritable bowel syndrome (IBS). The low fermentable oligo-, di-, mono-saccharides, and polyols (FODMAPs) diet is an evidence-based approach that is gaining popularity in many Western countries. The low FODMAP diet is based on restricting dietary intake of short chain carbohydrates that are slowly absorbed or indigestible and not absorbed during passage through the small intestine. These are collectively described as "FODMAPs" and comprise oligosaccharides (mostly fructans, galacto-oligosaccharides), sugar polyols, fructose in excess of glucose, and lactose in lactose malabsorbers. The general strategy of the diet is to avoid foods high in FODMAPs and replace them with foods low in FODMAPs, with long-term restriction limited to what is required to control symptoms. The likely mechanism of action is minimisation of the stimulation of mechanoreceptors exerted by distension of the intestinal lumen with water from osmotic effects and gases from bacterial fermentation in those with visceral hypersensitivity. The success of this dietary approach greatly depends on detailed knowledge about the FODMAP composition of food commonly consumed in that country. While the content of foods associated with East and Southeast Asian cuisines has not been fully explored, major high FODMAP sources are frequently used and include onion, garlic, shallots, legumes/pulses, and wheat-based products. Thus, this dietary approach holds great promise in treating IBS patients in East and Southeast Asia. The aim of this review is to highlight how the diet is implemented, its efficacy, and troublesome ingredients frequently used in Asian dishes.
Asia
;
Asia, Southeastern*
;
Asian Continental Ancestry Group
;
Carbohydrates
;
Diet*
;
Fermentation
;
Fructans
;
Fructose
;
Garlic
;
Gases
;
Glucose
;
Humans
;
Hypersensitivity
;
Intestine, Small
;
Irritable Bowel Syndrome
;
Lactose
;
Mechanoreceptors
;
Oligosaccharides
;
Onions
;
Shallots
;
Water
2.Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome.
Juan Juan FU ; Vanessa M MCDONALD ; Peter G GIBSON ; Jodie L SIMPSON
Allergy, Asthma & Immunology Research 2014;6(4):316-324
PURPOSE: The role of systemic inflammation on asthma-COPD overlap syndrome is unknown. This study aimed to examine systemic inflammation in asthma-COPD overlap syndrome, and to identify associations between clinical characteristics and inflammatory mediators in asthma-COPD overlap syndrome. METHODS: In 108 adults older than 55 years comprising healthy controls (n=29), asthma (n=16), COPD (n=21) and asthma-COPD overlap syndrome (n=42), serum high sensitivity C-reactive protein and Interleukin 6 (IL-6) were assayed. Spirometry, induced sputum, quality of life, comorbidities and medications were assessed, and their associations with asthma-COPD overlap syndrome were analyzed using logistic regression. Associations between systemic inflammatory mediators and clinical characteristics were tested in multivariate linear regression models. RESULTS: Patients with asthma-COPD overlap syndrome had significantly elevated IL-6 levels compared with healthy controls and asthmatics. Age, comorbidity index and IL-6 level were independently associated with asthma-COPD overlap syndrome. FEV1% predicted was inversely associated with IL-6 level, and cardiovascular disease was associated with an increased IL-6 level. Systemic markers were not associated with airway inflammation. CONCLUSIONS: Systemic inflammation is commonly present in asthma-COPD overlap syndrome, and asthma-COPD overlap syndrome resembled COPD in terms of systemic inflammation. IL-6 is a pivotal inflammatory mediator that may be involved in airflow obstruction and cardiovascular disease and may be an independent treatment target.
Adult*
;
Asthma
;
C-Reactive Protein
;
Cardiovascular Diseases
;
Comorbidity
;
Humans
;
Inflammation*
;
Interleukin-6
;
Linear Models
;
Logistic Models
;
Pulmonary Disease, Chronic Obstructive
;
Quality of Life
;
Spirometry
;
Sputum
3.Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome.
Juan Juan FU ; Vanessa M MCDONALD ; Peter G GIBSON ; Jodie L SIMPSON
Allergy, Asthma & Immunology Research 2014;6(4):316-324
PURPOSE: The role of systemic inflammation on asthma-COPD overlap syndrome is unknown. This study aimed to examine systemic inflammation in asthma-COPD overlap syndrome, and to identify associations between clinical characteristics and inflammatory mediators in asthma-COPD overlap syndrome. METHODS: In 108 adults older than 55 years comprising healthy controls (n=29), asthma (n=16), COPD (n=21) and asthma-COPD overlap syndrome (n=42), serum high sensitivity C-reactive protein and Interleukin 6 (IL-6) were assayed. Spirometry, induced sputum, quality of life, comorbidities and medications were assessed, and their associations with asthma-COPD overlap syndrome were analyzed using logistic regression. Associations between systemic inflammatory mediators and clinical characteristics were tested in multivariate linear regression models. RESULTS: Patients with asthma-COPD overlap syndrome had significantly elevated IL-6 levels compared with healthy controls and asthmatics. Age, comorbidity index and IL-6 level were independently associated with asthma-COPD overlap syndrome. FEV1% predicted was inversely associated with IL-6 level, and cardiovascular disease was associated with an increased IL-6 level. Systemic markers were not associated with airway inflammation. CONCLUSIONS: Systemic inflammation is commonly present in asthma-COPD overlap syndrome, and asthma-COPD overlap syndrome resembled COPD in terms of systemic inflammation. IL-6 is a pivotal inflammatory mediator that may be involved in airflow obstruction and cardiovascular disease and may be an independent treatment target.
Adult*
;
Asthma
;
C-Reactive Protein
;
Cardiovascular Diseases
;
Comorbidity
;
Humans
;
Inflammation*
;
Interleukin-6
;
Linear Models
;
Logistic Models
;
Pulmonary Disease, Chronic Obstructive
;
Quality of Life
;
Spirometry
;
Sputum
4.How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice
Nessmah SULTAN ; Jane E VARNEY ; Emma P HALMOS ; Jessica R BIESIEKIERSKI ; Chu K YAO ; Jane G MUIR ; Peter R GIBSON ; Caroline J TUCK
Journal of Neurogastroenterology and Motility 2022;28(3):343-356
Background/Aims:
The 3-phase fermentable oligo-, di-, mono-saccharides, and polyols (FODMAP) diet has shown a high level of efficacy in irritable bowel syndrome, largely based on dietitian delivered education. However, access to dietitians can be limited, and challenges exist when applying the diet to a wide range of cultures, such as limited FODMAP analysis of local foods. This review aims to discuss ways to optimally use the FODMAP diet in practice in a wide range of cultures, directed at gastroenterologists from a dietitian’s perspective.
Methods:
Recent literature was analysed via search databases including Medline, CINAHL, PubMed and Scopus.
Results:
The dietetic process involves detailed assessment and follow-up through the 3 stages of the FODMAP diet (restriction, re-introduction, and long-term maintenance). Emerging evidence suggests the diet can be delivered by other health professionals such as the gastroenterologist or nurse, but training on how to do so successfully would be needed. Self-guided approaches through use of technology or specialised food delivery services may be an alternative when dietitians are not available, but efficacy data is limited. Regardless of delivery mode, nutritional and psychological risks of the diet must be mitigated. Additionally, culturally appropriate education must be provided, with accommodations necessary when the FODMAP content of local foods are unknown.
Conclusion
While the diet has shown improved irritable bowel syndrome outcomes across studies, it is important to acknowledge the essential role of dietitians in implementing, tailoring, and managing the diet to achieve the best outcome for each individual.